DE69709691D1 - Pharmazeutische zusammenstellungen mit parthenium integrifolium oder mit einem extrakt oder einer komponente davon, verwendung dieses pflanzenmaterials zur herstellung von medizin und ein verfahren zur extraktherstellung von parthenium integrifolium - Google Patents
Pharmazeutische zusammenstellungen mit parthenium integrifolium oder mit einem extrakt oder einer komponente davon, verwendung dieses pflanzenmaterials zur herstellung von medizin und ein verfahren zur extraktherstellung von parthenium integrifoliumInfo
- Publication number
- DE69709691D1 DE69709691D1 DE69709691T DE69709691T DE69709691D1 DE 69709691 D1 DE69709691 D1 DE 69709691D1 DE 69709691 T DE69709691 T DE 69709691T DE 69709691 T DE69709691 T DE 69709691T DE 69709691 D1 DE69709691 D1 DE 69709691D1
- Authority
- DE
- Germany
- Prior art keywords
- extract
- production
- parthenium integrifolium
- compilations
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK115896 | 1996-10-21 | ||
US3139596P | 1996-11-19 | 1996-11-19 | |
PCT/DK1997/000457 WO1998017292A1 (en) | 1996-10-21 | 1997-10-20 | Pharmaceutical compositions containing parthenium integrifolium or parts thereof or an extract or component thereof, the use of such plant material for preparing certain medicines, and a method of preparing an extract of parthenium integrifolium |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69709691D1 true DE69709691D1 (de) | 2002-02-21 |
DE69709691T2 DE69709691T2 (de) | 2002-08-22 |
Family
ID=26065310
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69709691T Expired - Fee Related DE69709691T2 (de) | 1996-10-21 | 1997-10-20 | Pharmazeutische zusammenstellungen mit parthenium integrifolium oder mit einem extrakt oder einer komponente davon, verwendung dieses pflanzenmaterials zur herstellung von medizin und ein verfahren zur extraktherstellung von parthenium integrifolium |
Country Status (10)
Country | Link |
---|---|
US (1) | US6217877B1 (de) |
EP (1) | EP1007067B1 (de) |
JP (1) | JP4346685B2 (de) |
AT (1) | ATE211918T1 (de) |
AU (1) | AU711019B2 (de) |
DE (1) | DE69709691T2 (de) |
DK (1) | DK1007067T3 (de) |
ES (1) | ES2172006T3 (de) |
PT (1) | PT1007067E (de) |
WO (1) | WO1998017292A1 (de) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6277978B1 (en) | 1995-12-22 | 2001-08-21 | University Of Utah Research Foundation | KVLQT1—a long QT syndrome gene |
DE60023119T2 (de) * | 1999-03-10 | 2006-07-20 | G.D. Searle Llc | Zusammensetzungen zur verabreichung eines cyclooxygenase-2-hemmers an tiere |
US20010024664A1 (en) * | 1999-03-19 | 2001-09-27 | Obukowicz Mark G. | Selective COX-2 inhibition from edible plant extracts |
CO5190664A1 (es) | 1999-06-30 | 2002-08-29 | Pfizer Prod Inc | Terapia de combinacion para el tratamiento de migrana administracion de un receptor 5ht, cafeina y un inhibidor de ciclooxigenasa-2 |
AU2001285334A1 (en) | 2000-08-29 | 2002-03-13 | Peter Van Patten | Combination for the treatment of migraine comprising a cyclooxygenase-2 inhibitor and acetylsalicylic acid |
JP2004529079A (ja) * | 2000-12-15 | 2004-09-24 | ファルマシア・コーポレーション | 植物抽出物による選択的cox−2阻害 |
AU2003237487A1 (en) * | 2002-06-14 | 2003-12-31 | Smith And Nephew, Inc. | Device and methods for placing external fixation elements |
US20040086579A1 (en) * | 2002-11-05 | 2004-05-06 | Higgins James W. | Dietary supplement comprising parthenolide |
US7192614B2 (en) | 2002-11-05 | 2007-03-20 | Gelstat Corporation | Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms |
TWI344959B (en) * | 2003-04-02 | 2011-07-11 | Nat Health Research Institutes | Treatment of hepatitis c virus infection with sesquiterpene lactones |
US20040247705A1 (en) * | 2003-06-06 | 2004-12-09 | Roberts Stephen C. | Transdermal compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms |
US20040247706A1 (en) * | 2003-06-06 | 2004-12-09 | Roberts Stephen C. | Transdermal dietary supplement comprising parthenolide |
US20050058673A1 (en) * | 2003-09-09 | 2005-03-17 | 3M Innovative Properties Company | Antimicrobial compositions and methods |
US20060051384A1 (en) * | 2004-09-07 | 2006-03-09 | 3M Innovative Properties Company | Antiseptic compositions and methods of use |
US8198326B2 (en) * | 2004-09-07 | 2012-06-12 | 3M Innovative Properties Company | Phenolic antiseptic compositions and methods of use |
US9028852B2 (en) * | 2004-09-07 | 2015-05-12 | 3M Innovative Properties Company | Cationic antiseptic compositions and methods of use |
ES2459742T3 (es) * | 2004-12-22 | 2014-05-12 | Ono Pharmaceutical Co., Ltd. | Compuesto tricíclico y uso del mismo |
CN101175474B (zh) * | 2005-03-10 | 2011-09-07 | 3M创新有限公司 | 降低微生物污染的方法 |
US8476319B2 (en) * | 2005-03-10 | 2013-07-02 | 3M Innovative Properties Company | Methods of treating ear infections |
US9826770B2 (en) * | 2005-03-10 | 2017-11-28 | 3M Innovative Properties Company | Antimicrobial compositions comprising esters of hydroxycarboxylic acids |
WO2007137456A1 (fr) * | 2006-06-01 | 2007-12-06 | Yun Cheng | Peptide pour la prévention ou le traitement d'atteinte hépatique et son dérivé ainsi que son utilisation |
CN104721602A (zh) * | 2013-12-19 | 2015-06-24 | 汤丽娟 | 一种治疗腹型偏头痛的中药 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4058594A (en) * | 1974-04-25 | 1977-11-15 | John Williams | Immuno-suppressive agents |
CA1270843A (en) * | 1982-05-19 | 1990-06-26 | Edward Stewart Johnson | Sesquiterpene lactones |
DE3638715A1 (de) * | 1986-11-13 | 1988-05-26 | Lohmann Rudolf Lomapharm | Sesquiterpenverbindungen, verfahren zu ihrer isolierung und arzneimittel, enthaltend diese verbindungen |
US5053387A (en) * | 1987-02-20 | 1991-10-01 | Shriners Hospitals For Crippled Children | Omega-3 fatty acids in traumatic injury treatment |
WO1993013787A1 (en) * | 1987-03-27 | 1993-07-22 | Michio Fujimaki | Immunopotentiating agent |
-
1997
- 1997-10-20 ES ES97944746T patent/ES2172006T3/es not_active Expired - Lifetime
- 1997-10-20 PT PT97944746T patent/PT1007067E/pt unknown
- 1997-10-20 AU AU46158/97A patent/AU711019B2/en not_active Ceased
- 1997-10-20 EP EP97944746A patent/EP1007067B1/de not_active Expired - Lifetime
- 1997-10-20 WO PCT/DK1997/000457 patent/WO1998017292A1/en active IP Right Grant
- 1997-10-20 JP JP51105798A patent/JP4346685B2/ja not_active Expired - Lifetime
- 1997-10-20 DE DE69709691T patent/DE69709691T2/de not_active Expired - Fee Related
- 1997-10-20 AT AT97944746T patent/ATE211918T1/de not_active IP Right Cessation
- 1997-10-20 DK DK97944746T patent/DK1007067T3/da active
-
1999
- 1999-04-21 US US09/299,104 patent/US6217877B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ATE211918T1 (de) | 2002-02-15 |
JP2001501919A (ja) | 2001-02-13 |
EP1007067A1 (de) | 2000-06-14 |
DE69709691T2 (de) | 2002-08-22 |
EP1007067B1 (de) | 2002-01-16 |
JP4346685B2 (ja) | 2009-10-21 |
AU711019B2 (en) | 1999-10-07 |
WO1998017292A1 (en) | 1998-04-30 |
ES2172006T3 (es) | 2002-09-16 |
PT1007067E (pt) | 2002-07-31 |
US6217877B1 (en) | 2001-04-17 |
AU4615897A (en) | 1998-05-15 |
DK1007067T3 (da) | 2002-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69709691D1 (de) | Pharmazeutische zusammenstellungen mit parthenium integrifolium oder mit einem extrakt oder einer komponente davon, verwendung dieses pflanzenmaterials zur herstellung von medizin und ein verfahren zur extraktherstellung von parthenium integrifolium | |
NO972315D0 (no) | Aerogelholdig komposittmateriale, fremgangsmåte for fremstilling derav samt anvendelse av materialet | |
DE59601880D1 (de) | Verfahren zur herstellung hydrophiler oder teilweise hydrophiler, anorganischer aerogele | |
PT923293E (pt) | Tratamento da diarreia | |
ATE350048T1 (de) | Neue synergistische zusammensetzungen, die aromatische verbindungen und in alpinia galanga vorhandene terpenoide enthalten | |
BG110703A (en) | PHARMACEUTICAL COMPOSITION, INCLUDING HUMAN ANTIBODIES CONNECTING HUMAN TNF ALPHA AND HIS APPLICATION | |
MY101842A (en) | Treatment of oral diseases. | |
DE69715217D1 (de) | Konjugierte linoleinsäure zur erhaltung oder erhöhung des knochenmineraliengehaltes | |
ES8302017A1 (es) | Procedimiento para la preparacion de un alto concentrado de factor viii (ahf). | |
DE68928351D1 (de) | Verfahren zur Herstellung von Polymerteilchen, Verfahren zur Herstellung von "Toner"-teilchen, und durch dieses Verfahren hergestellte Teilchen | |
ES2148813T3 (es) | Procedimiento para la elaboracion de plantas que contienen proteinas. | |
ATE254924T1 (de) | Stör-notokord zur verminderung der symptome / behandlung von arthritis | |
Guenther | The role of nutritional therapy in alcoholism treatment. | |
DE69624370T2 (de) | Verfarhen zur herstellung von glycogen oder glycogenreichem hefeextrakt aus hefezellen und kosmetische zusammensetzungen, die diese enthalten | |
CA2075077A1 (en) | Stevia extract-containing liquid internal medicine and method of preparing the same | |
ES8104315A1 (es) | Un procedimiento de obtencion de un extracto de las fraccio-nes polares de los helechos de la familia polypodiaceae. | |
FR2513122B1 (de) | ||
DE59912657D1 (de) | Verfahren zur herstellung einer biologischen substanz sowie derartige substanz und deren verwendung | |
NZ307579A (en) | Recombinant preduodenal lipases and polypeptides derivatives produced by plants, processes for obtaining them and their uses | |
DE69429521T2 (de) | Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung | |
DE69319341D1 (de) | Verfahren und zusammensetzungen zur behandlung von krankheiten verbunden mit mangelhaften immunfunktion | |
HU0102043D0 (en) | Pharmaceutical compounds which interact with an ca2+ channel alpha2delta subunit | |
DE68922013D1 (de) | Verfahren zur Herstellung von rektifiziertem Vetiverol und Vetiveröl, und diese enthaltende Parfümeriezusammensetzungen. | |
DE3878529D1 (de) | Vorrichtung zur behandlung von verstauchungen, insbesondere der sprunggelenke sowie zur vermeidung von dabei auftretenden bestimmten komplikationen. | |
RO86562B1 (ro) | Compozitie vegetala medicamentoasa pentru tratarea unor afectiuni hepato-biliare |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: EUROVITA A/S, KARLSLUNDE, DK |
|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |